Molnupiravir (Norwegian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Molnupiravir" in Norwegian language version.

refsWebsite

Global rank Norwegian rank

5doi.org

2^nd place

9^th place

5wikidata.org

43^rd place

11^th place

3nih.gov

4^th place

23^rd place

2forbes.com

54^th place

189^th place

1dn.se

679^th place

272^nd place

1clinicaltrials.gov

5,225^th place

9,018^th place

1arstechnica.com

388^th place

1,208^th place

1gov.uk

432^nd place

508^th place

1elsevier.com

610^th place

1,338^th place

1drugdiscoverytrends.com

low place

1clinicaltrialsarena.com

low place

1oup.com

485^th place

429^th place

1trialsitenews.com

low place

arstechnica.com

«Meet molnupiravir, Merck’s Thor-inspired pill that hammers COVID». Ars Technica. 1. oktober 2021.

clinicaltrials.gov

Klinisk studie NCT04575597 på ClinicalTrials.gov

clinicaltrialsarena.com

Reynald Castaneda; Sean Rai-Roche (29. januar 2021). «Ridgeback/Merck’s molnupiravir for Covid-19 has MOA, administration advantages but Phase IIa faces execution obstacles, may have value gaps». Clinical Trials Arena.

dn.se

DN.se: Svenskar ska erbjudas covidmedicin på försök, Dagens Nyheter 2021-05-25

doi.org

Mart Toots; Jeong-Joong Yoon; Robert M Cox; m.fl. (1. oktober 2019). «Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia». Science Translational Medicine. 11 (515). PMC 6848974 . PMID 31645453. doi:10.1126/SCITRANSLMED.AAX5866. Wikidata Q90910407.
Mart Toots; Jeong-Joong Yoon; Michael Hart; Michael G Natchus; George R Painter; Richard K Plemper (25. desember 2019). «Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model». Translational Research. 218: 16-28. PMID 31945316. doi:10.1016/J.TRSL.2019.12.002. Wikidata Q92690560.
Shuntai Zhou; Collin S Hill; Sanjay Sarkar; m.fl. (2. august 2021). «β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells». The Journal of Infectious Diseases. 224 (3): 415-419. PMC 8136050 . PMID 33961695. doi:10.1093/INFDIS/JIAB247. Wikidata Q108084287.
Awadhesh Kumar Singh; Akriti Singh; Ritu Singh; Anoop Misra (november 2021). «Molnupiravir in COVID-19: A systematic review of literature». Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 15 (6). doi:10.1016/J.DSX.2021.102329. Wikidata Q109580545.
Sean Troth; Joan Butterton; Carisa Stadlman DeAnda; Patricia Escobar; Jay Grobler; Daria Hazuda; George Painter (28. oktober 2021). «Letter to the Editor in Response to Zhou et al». The Journal of Infectious Diseases. 224 (8). doi:10.1093/INFDIS/JIAB362. Wikidata Q109539346.

drugdiscoverytrends.com

Brian Buntz (4. oktober 2021). «Early safety concerns accompanied Merck’s molnupiravir, the first potential oral COVID-19 therapy». Drug Discovery & Development.

elsevier.com

linkinghub.elsevier.com

Awadhesh Kumar Singh; Akriti Singh; Ritu Singh; Anoop Misra (november 2021). «Molnupiravir in COVID-19: A systematic review of literature». Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 15 (6). doi:10.1016/J.DSX.2021.102329. Wikidata Q109580545.

forbes.com

William A. Haseltine (15. november 2021). «Supercharging New Viral Variants: The Dangers Of Molnupiravir (Part 1)». Forbes.
William A. Haseltine (15. november 2021). «Harming Those Who Receive It: The Dangers Of Molnupiravir (Part 2)». Forbes.

gov.uk

«First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA». Medicines and Healthcare products Regulatory Agency. 4. november 2021.

nih.gov

ncbi.nlm.nih.gov

Mart Toots; Jeong-Joong Yoon; Robert M Cox; m.fl. (1. oktober 2019). «Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia». Science Translational Medicine. 11 (515). PMC 6848974 . PMID 31645453. doi:10.1126/SCITRANSLMED.AAX5866. Wikidata Q90910407.
Mart Toots; Jeong-Joong Yoon; Michael Hart; Michael G Natchus; George R Painter; Richard K Plemper (25. desember 2019). «Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model». Translational Research. 218: 16-28. PMID 31945316. doi:10.1016/J.TRSL.2019.12.002. Wikidata Q92690560.
Shuntai Zhou; Collin S Hill; Sanjay Sarkar; m.fl. (2. august 2021). «β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells». The Journal of Infectious Diseases. 224 (3): 415-419. PMC 8136050 . PMID 33961695. doi:10.1093/INFDIS/JIAB247. Wikidata Q108084287.

oup.com

academic.oup.com

Sean Troth; Joan Butterton; Carisa Stadlman DeAnda; Patricia Escobar; Jay Grobler; Daria Hazuda; George Painter (28. oktober 2021). «Letter to the Editor in Response to Zhou et al». The Journal of Infectious Diseases. 224 (8). doi:10.1093/INFDIS/JIAB362. Wikidata Q109539346.

trialsitenews.com

«Cancer And Birth Defects: Potential Risks Of Molnupiravir?». TrialSiteNews. 15. november 2021.

wikidata.org

Mart Toots; Jeong-Joong Yoon; Robert M Cox; m.fl. (1. oktober 2019). «Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia». Science Translational Medicine. 11 (515). PMC 6848974 . PMID 31645453. doi:10.1126/SCITRANSLMED.AAX5866. Wikidata Q90910407.
Mart Toots; Jeong-Joong Yoon; Michael Hart; Michael G Natchus; George R Painter; Richard K Plemper (25. desember 2019). «Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model». Translational Research. 218: 16-28. PMID 31945316. doi:10.1016/J.TRSL.2019.12.002. Wikidata Q92690560.
Shuntai Zhou; Collin S Hill; Sanjay Sarkar; m.fl. (2. august 2021). «β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells». The Journal of Infectious Diseases. 224 (3): 415-419. PMC 8136050 . PMID 33961695. doi:10.1093/INFDIS/JIAB247. Wikidata Q108084287.
Awadhesh Kumar Singh; Akriti Singh; Ritu Singh; Anoop Misra (november 2021). «Molnupiravir in COVID-19: A systematic review of literature». Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 15 (6). doi:10.1016/J.DSX.2021.102329. Wikidata Q109580545.
Sean Troth; Joan Butterton; Carisa Stadlman DeAnda; Patricia Escobar; Jay Grobler; Daria Hazuda; George Painter (28. oktober 2021). «Letter to the Editor in Response to Zhou et al». The Journal of Infectious Diseases. 224 (8). doi:10.1093/INFDIS/JIAB362. Wikidata Q109539346.